GALLO, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 2.370
NA - Nord America 192
EU - Europa 124
SA - Sud America 8
AF - Africa 2
OC - Oceania 1
Totale 2.697
Nazione #
SG - Singapore 2.204
US - Stati Uniti d'America 186
CN - Cina 89
HK - Hong Kong 51
IT - Italia 31
DE - Germania 24
CZ - Repubblica Ceca 19
GB - Regno Unito 18
FR - Francia 10
NL - Olanda 10
IN - India 9
BR - Brasile 7
PH - Filippine 5
JP - Giappone 4
MX - Messico 4
FI - Finlandia 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
CA - Canada 2
NO - Norvegia 2
PL - Polonia 2
AU - Australia 1
CY - Cipro 1
ES - Italia 1
ID - Indonesia 1
MA - Marocco 1
PE - Perù 1
SA - Arabia Saudita 1
SE - Svezia 1
SY - Repubblica araba siriana 1
TR - Turchia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 2.697
Città #
Hong Kong 50
Hefei 42
Ashburn 40
Singapore 40
Boardman 25
Beijing 19
Dallas 18
Brno 15
London 14
Munich 14
Rome 14
Shanghai 12
Council Bluffs 8
West Jordan 8
Los Angeles 7
Paris 6
Amsterdam 5
San Francisco 5
Bacolod City 4
Bengaluru 4
Olomouc 4
Brooklyn 3
Chicago 3
Mexico City 3
New York 3
Nuremberg 3
Pune 3
Tokyo 3
Washington 3
Aversa 2
Bologna 2
Boston 2
Caldogno 2
Durham 2
Hamar 2
Hanover 2
Santa Clara 2
Seattle 2
Secaucus 2
Sona 2
São Paulo 2
The Dalles 2
Toronto 2
Turku 2
Warsaw 2
Zhoukou 2
Amargosa 1
Annapolis 1
Belo Horizonte 1
Bismarck 1
Buffalo 1
Campinas 1
Casablanca 1
Chennai 1
Fuzhou 1
Guangzhou 1
Halfweg 1
Handan 1
Helsinki 1
Johannesburg 1
Liaocheng 1
Lima 1
Manchester 1
Mauá 1
Melbourne 1
Mirabella Eclano 1
Nanchang 1
Newark 1
Nicosia 1
Norfolk 1
Orem 1
Phú Thọ 1
Pisa 1
Raleigh 1
Riyadh 1
San Jose 1
Sombrio 1
Springfield 1
Stockholm 1
Stow 1
Suffern 1
Xi'an 1
Totale 448
Nome #
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 199
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 193
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 186
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 183
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 179
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 177
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 176
Assessment of liver function by the exhaled breath-print during chronic liver disease 169
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 166
The Italian multiple sclerosis register 156
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 152
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 129
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 96
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 91
In situ electrostimulation drives a regenerative shift in the zone of infarcted myocardium 88
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 86
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 83
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 73
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 73
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 29
Hepatic complications of bariatric surgery : the reverse side of the coin 24
Totale 2.708
Categoria #
all - tutte 9.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 1 2 0 0 0 0 0 2 0 0 26
2022/202316 1 0 2 3 2 0 0 0 0 2 6 0
2023/2024119 2 3 5 8 5 23 2 7 16 16 15 17
2024/20252.404 22 5 31 10 15 25 27 1 40 110 1.046 1.072
2025/2026138 74 48 16 0 0 0 0 0 0 0 0 0
Totale 2.708